Altimmune Intangible Assets vs Net Invested Capital Analysis
| ALT Stock | USD 6.55 0.15 2.34% |
Altimmune financial indicator trend analysis is way more than just evaluating Altimmune prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Altimmune is a good investment. Please check the relationship between Altimmune Intangible Assets and its Net Invested Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altimmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.
Intangible Assets vs Net Invested Capital
Intangible Assets vs Net Invested Capital Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Altimmune Intangible Assets account and Net Invested Capital. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Altimmune's Intangible Assets and Net Invested Capital is 0.14. Overlapping area represents the amount of variation of Intangible Assets that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of Altimmune, assuming nothing else is changed. The correlation between historical values of Altimmune's Intangible Assets and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Intangible Assets of Altimmune are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Intangible Assets i.e., Altimmune's Intangible Assets and Net Invested Capital go up and down completely randomly.
Correlation Coefficient | 0.14 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Intangible Assets
Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.Net Invested Capital
The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.Most indicators from Altimmune's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Altimmune current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altimmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.At this time, Altimmune's Tax Provision is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 44.70 in 2024, despite the fact that Enterprise Value Over EBITDA is likely to grow to (5.31).
| 2021 | 2022 | 2023 | 2024 (projected) | Research Development | 74.5M | 70.5M | 65.3M | 68.6M | Depreciation And Amortization | 11.2M | 2.8M | 477K | 453.2K |
Altimmune fundamental ratios Correlations
Click cells to compare fundamentals
Altimmune Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Altimmune fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 54.1M | 245.1M | 218.9M | 206.9M | 210.6M | 221.2M | |
| Other Current Liab | 3.6M | 11.0M | 6.1M | 11.8M | 9.6M | 17.1M | |
| Total Current Liabilities | 3.9M | 12.0M | 18.3M | 17.1M | 12.1M | 21.2M | |
| Total Stockholder Equity | 45.5M | 225.9M | 199.1M | 185.3M | 194.1M | 203.8M | |
| Net Debt | (7.2M) | (114.1M) | (188.8M) | (110.0M) | (134.5M) | (127.8M) | |
| Retained Earnings | (137.4M) | (186.4M) | (293.2M) | (377.9M) | (466.3M) | (443.0M) | |
| Accounts Payable | 18.2K | 612.3K | 2.0M | 4.8M | 2.1M | 1.5M | |
| Cash | 9.0M | 115.9M | 190.3M | 111.1M | 135.2M | 141.9M | |
| Cash And Short Term Investments | 37.2M | 215.9M | 190.3M | 184.9M | 197.9M | 207.7M | |
| Common Stock Total Equity | 876.0 | 1.5K | 3.7K | 4.1K | 4.7K | 3.9K | |
| Common Stock Shares Outstanding | 13.1M | 25.6M | 41.3M | 46.9M | 53.2M | 55.9M | |
| Liabilities And Stockholders Equity | 54.1M | 245.1M | 218.9M | 206.9M | 210.6M | 221.2M | |
| Other Current Assets | 504.4M | 2.0B | 13.4B | 5.4M | 6.8M | 6.5M | |
| Other Stockholder Equity | 187.9M | 417.3M | 497.3M | 568.4M | 665.4M | 698.7M | |
| Total Liab | 8.5M | 19.2M | 19.7M | 21.6M | 16.5M | 27.3M | |
| Total Current Assets | 39.4M | 230.3M | 204.1M | 192.8M | 209.5M | 220.0M | |
| Common Stock | 1.5K | 3.7K | 4.1K | 5K | 7K | 4.2K | |
| Other Assets | 128.5K | 977.2K | 73.8K | 19K | 1.0 | 0.95 | |
| Non Current Liabilities Total | 4.6M | 7.2M | 1.5M | 4.6M | 4.4M | 4.7M | |
| Short Term Debt | 259.4K | 356.7K | 411.5K | 452K | 496K | 471.2K | |
| Short Long Term Debt Total | 1.7M | 1.8M | 1.5M | 1.1M | 671K | 637.5K | |
| Property Plant And Equipment Net | 1.8M | 2.0M | 1.4M | 1.1M | 1.0M | 1.5M | |
| Non Current Assets Total | 14.7M | 14.9M | 14.7M | 14.1M | 1.1M | 1.1M | |
| Non Currrent Assets Other | 128.5K | 73.4K | 872.0K | 615K | 100.0K | 95.0K | |
| Net Receivables | 1.7M | 12.4M | 5.8M | 2.5M | 4.9M | 5.0M | |
| Property Plant And Equipment Gross | 1.8M | 2.0M | 1.4M | 2.6M | 2.6M | 1.6M | |
| Accumulated Other Comprehensive Income | (5.0M) | (5.0M) | (5.0M) | (5.2M) | (5.0M) | (4.8M) | |
| Intangible Assets | 12.7M | 12.8M | 12.4M | 12.4M | 14.3M | 11.8M | |
| Net Tangible Assets | 32.8M | 213.1M | 186.7M | 172.9M | 198.8M | 208.7M | |
| Long Term Debt | 1.9M | 1.9M | 1.8M | 1.5M | 1.7M | 1.5M | |
| Retained Earnings Total Equity | (116.9M) | (137.4M) | (186.4M) | (293.2M) | (337.1M) | (354.0M) | |
| Capital Surpluse | 170.2M | 187.9M | 417.3M | 497.3M | 571.9M | 600.5M | |
| Property Plant Equipment | 1.1M | 1.1M | 1.4M | 1.7M | 1.9M | 2.0M | |
| Long Term Debt Total | 1.9M | 1.9M | 1.8M | 1.5M | 1.7M | 2.0M | |
| Non Current Liabilities Other | 2.8M | 5.4M | 1.5M | 3.9M | 4.2M | 4.4M | |
| Other Liab | 3.1M | 7.2M | 330.5K | 3.9M | 4.5M | 3.3M |
Altimmune Implied Volatility | 126.63 |
Altimmune's implied volatility exposes the market's sentiment of Altimmune stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Altimmune's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Altimmune stock will not fluctuate a lot when Altimmune's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Altimmune in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Altimmune's short interest history, or implied volatility extrapolated from Altimmune options trading.
Pair Trading with Altimmune
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Altimmune position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altimmune will appreciate offsetting losses from the drop in the long position's value.Moving together with Altimmune Stock
| 0.71 | DVAX | Dynavax Technologies Financial Report 7th of May 2024 | PairCorr |
| 0.7 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.67 | ELAN | Elanco Animal Health Financial Report 14th of May 2024 | PairCorr |
Moving against Altimmune Stock
| 0.7 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.59 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.41 | HCM | HUTCHMED DRC | PairCorr |
The ability to find closely correlated positions to Altimmune could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Altimmune when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Altimmune - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Altimmune to buy it.
The correlation of Altimmune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Altimmune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Altimmune moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Altimmune can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altimmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Altimmune Stock analysis
When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Altimmune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Altimmune. If investors know Altimmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Altimmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.66) | Revenue Per Share 0.008 | Quarterly Revenue Growth 180 | Return On Assets (0.25) | Return On Equity (0.47) |
The market value of Altimmune is measured differently than its book value, which is the value of Altimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Altimmune's value that differs from its market value or its book value, called intrinsic value, which is Altimmune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Altimmune's market value can be influenced by many factors that don't directly affect Altimmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Altimmune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Altimmune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Altimmune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.